We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · July 27, 2021

GLP-1 Receptor Agonists Slow Cognitive Decline in T2D

Journal of the American Heart Association


Additional Info

Journal of the American Heart Association
Activation of Glucagon-Like Peptide-1 Receptor Ameliorates Cognitive Decline in Type 2 Diabetes Mellitus Through a Metabolism-Independent Pathway
J Am Heart Assoc 2021 Jul 20;10(14)e020734, Q Li, M Jia, Z Yan, Q Li, F Sun, C He, Y Li, X Zhou, H Zhang, X Liu, X Bu, P Gao, H He, Z Zhao, Z Zhu

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading